EFFECTIVE Act

United States117th CongressHR-8586House of Representatives
Updated: Jul 28, 2022

Summary

Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug upon a determination that the drug does not provide a significant advantage or clinical superiority compared to other drugs.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-4340: EFFECTIVE Act

Introduced in Senate

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

All available records shown.